Trial Profile
Multinational randomised controlled clinical trial of etoricoxib in the treatment of rheumatoid arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Jul 2009
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary) ; Naproxen
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Merck & Co
- 11 Dec 2006 New trial record.